1) 日本泌尿器科学会, 他 (編) : LOH症候群 (加齢男性・性腺機能低下症) 診療の手引き. 医学図書出版, 2022
2) Braga-Basaria M, et al : Metabolic syndrome in men with prostate cancer undergoing long-term androgen-deprivation therapy. J Clin Oncol 24 : 3979-3983, 2006
3) Braga PC, et al : Late-onset hypogonadism and lifestyle-related metabolic disorders. Andrology 8 : 1530-1538, 2020
4) Tanabe M, et al : Total testosterone is the most valuable indicator of metabolic syndrome among various testosterone values in middle-aged Japanese men. Endocrine J 62 : 123-132, 2015
5) Tsujimura A, et al : Is low testosterone concentration a risk factor for metabolic syndrome in healthy middle-aged men? Urology 3 : 814-819, 2013
6) Laaksonen DE, et al : Testosterone and sex hormone-binding globulin predict the metabolic syndrome and diabetes in middle-aged men. Diabetes Care 27 : 1036-1041, 2004
7) Dhindsa S, et al : Testosterone concentrations in diabetic and nondiabetic obese men. Diabetes Care 33 : 1186-1192, 2010
8) López-Alvarenga JC, et al : Poorly controlled type I diabetes mellitus in young men selectively suppresses luteinizing hormone secretory burst mass. J Clin Endocrinol Metab 87 : 5507-5515, 2002
9) Yassin A, et al : Testosterone Therapy in Men With Hypogonadism Prevents Progression From Prediabetes to Type 2 Diabetes : Eight-Year Data From a Registry Study. Diabetes Care 42 : 1104-1111, 2019
10) Wittert G, et al : Testosterone treatment to prevent or revert type 2 diabetes in men enrolled in a lifestyle programme (T4DM) : a randomised, double-blind, placebo-controlled, 2-year, phase 3b trial. Lancet Diabetes Endocrinol 9 : 32-45, 2021
11) Bhasin S, et al : Effect of Testosterone on Progression From Prediabetes to Diabetes in Men With Hypogonadism : A Substudy of the TRAVERSE Randomized Clinical Trial. JAMA Intern Med 184 : 353-362, 2024